- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 24.68M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 22M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 24.77M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $15K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $6.44K |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $10.03M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $24.34M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $31.17M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $45.34M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $46.01M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $26.05M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $27.17M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.65M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.57M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.83M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.82M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $49.39M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $50.82M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $51.17M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $52.82M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.44M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.91M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $817.04K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $1.21M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$519.86K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.02M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$671.19K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$2.35M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $4.17M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $2.37M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.9M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $2.84M |
| Revenue | Q1 2026 · Mar 31, 2026 | $8.07M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $5.21M |